Comparing diabetes treatments for people with normal weight
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests two medications—pioglitazone (a pill) and tirzepatide (an injection)—in people with type 2 diabetes who have a normal body weight. It aims to find which treatment works better for this specific group.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 30 and 70 years old.
- You have type 2 diabetes (or pre-diabetes) and your blood sugar levels (A1c) are between 5.7% and 8%.
- Your body mass index (BMI) is between 19 and 24.9, which is in the normal weight range.
- Your weight has not changed by more than 2 kg (about 4.4 lbs) in the last 3 months.
- You are not currently taking insulin or pioglitazone, and you haven't used pioglitazone before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at differences in body fat to understand why some people develop type 2 diabetes. You may be asked for blood tests and health information to see if your diabetes risk and body fat patterns are linked.
This trial compares two medications, dapagliflozin and empagliflozin, to see which works better and is safer for people with type 2 diabetes and a high body mass index (BMI). If you are an adult with type 2 diabetes and a BMI of 23 or higher, this study might help find a treatment that also supports weight loss.
This study looks at adults with prediabetes—specifically abnormal fasting and/or 2-hour blood sugar tests—to see whether a treatment helps improve sugar control. You may also be compared with people who have normal blood sugar (the control group).
This study compares people with type 2 diabetes and higher body weight who meet criteria for metabolic (weight-loss) surgery versus people with mild obesity who do not. It aims to see whether surgery improves diabetes-related outcomes more than usual medical care.
This study tests a new medicine called NNC0487-0111 to see how well it helps people with excess body weight and type 2 diabetes lose weight, compared to another medicine called semaglutide. It may be an option if you have type 2 diabetes and are looking to manage your weight.
This study compares an AI-powered lifestyle program to a medication called tirzepatide for helping people with obesity and newly diagnosed type 2 diabetes lose weight and manage their blood sugar. It aims to find which approach works better and is safer.
Hear when a new Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.